These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Huntington's Disease Gene Expansion Carriers Are Aware of Their Degree of Apathy. Baake V; van Duijn E; Roos RAC J Neuropsychiatry Clin Neurosci; 2018; 30(3):183-187. PubMed ID: 29843585 [TBL] [Abstract][Full Text] [Related]
8. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period. van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661 [TBL] [Abstract][Full Text] [Related]
9. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study. Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091 [TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease. Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966 [TBL] [Abstract][Full Text] [Related]
11. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study. Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464 [TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment related to apathy in early Huntington's disease. Baudic S; Maison P; Dolbeau G; Boissé MF; Bartolomeo P; Dalla Barba G; Traykov L; Bachoud-Lévi AC Dement Geriatr Cogn Disord; 2006; 21(5-6):316-21. PubMed ID: 16484810 [TBL] [Abstract][Full Text] [Related]
17. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR; Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354 [TBL] [Abstract][Full Text] [Related]
18. "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. Duff K; Paulsen JS; Beglinger LJ; Langbehn DR; Wang C; Stout JC; Ross CA; Aylward E; Carlozzi NE; Queller S; J Neuropsychiatry Clin Neurosci; 2010; 22(2):196-207. PubMed ID: 20463114 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. Thompson JC; Harris J; Sollom AC; Stopford CL; Howard E; Snowden JS; Craufurd D J Neuropsychiatry Clin Neurosci; 2012; 24(1):53-60. PubMed ID: 22450614 [TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB; J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]